Corcept Therapeutics (CORT) Misses Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $114.82 +4.11%
Revenue Growth %: +56.0%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +56.0%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of $0.14, $0.05 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $105.7 million versus the consensus estimate of $104.91 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Microchip Technology completes acquisition of Hailo
- Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
